<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00910481</url>
  </required_header>
  <id_info>
    <org_study_id>ISRCTN40553718</org_study_id>
    <secondary_id>ISRCTN40553718</secondary_id>
    <nct_id>NCT00910481</nct_id>
  </id_info>
  <brief_title>Balloon Pump Assisted Coronary Intervention Study</brief_title>
  <acronym>BCIS-1</acronym>
  <official_title>Balloon Pump Assisted Coronary Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>British Cardiovascular Intervention Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>British Cardiovascular Intervention Society</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the hypothesis that elective use of the Intra-Aortic Balloon Pump (IABP)&#xD;
      in patients undergoing high-risk Percutaneous Coronary Intervention (PCI) will reduce the&#xD;
      rate of in-hospital major adverse cardiac and cerebrovascular events compared to patients who&#xD;
      are managed without planned insertion of IABP.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major Adverse Cardiac and Cerebrovascular Events</measure>
    <time_frame>Hospital discharge or 28 days following PCI, whichever occurs sooner</time_frame>
    <description>(composite endpoint of death, acute myocardial infarction, further revascularization or cerebrovascular event)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause Mortality</measure>
    <time_frame>6-months following randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Procedural Complications</measure>
    <time_frame>Duration of PCI procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding Complications (Major and Minor)</measure>
    <time_frame>Hospital Discharge or 28 days following PCI (whichever occurs sooner)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Access Site Complications</measure>
    <time_frame>Hospital Discharge or 28 days following PCI (whichever occurs sooner)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transient Ischemic Attack</measure>
    <time_frame>Hospital Discharge or 28 days following PCI (whichever occurs sooner)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>Hospital Discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>Duration of PCI procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">301</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Left Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>Elective IABP Insertion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No Planned IABP Insertion</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intra-Aortic Balloon Pump</intervention_name>
    <description>Elective IABP insertion before PCI</description>
    <arm_group_label>Elective IABP Insertion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  impaired left ventricular function (Ejection Fraction &lt; 30%)&#xD;
&#xD;
          -  large area of myocardium at risk (BCIS-1 Myocardial Jeopardy Score â‰¥ 8/12)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cardiogenic shock&#xD;
&#xD;
          -  acute STEMI within previous 48 hours&#xD;
&#xD;
          -  complications of recent AMI (including ventricular septal defect, severe mitral&#xD;
             regurgitation, intractable ventricular arrhythmias)&#xD;
&#xD;
          -  contraindications to IABP use (including significant iliac or femoral arterial disease&#xD;
             and more than mild aortic regurgitation)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Divaka Perera, MRCP, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's and St Thomas' Hospital NHSFT, London, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon Redwood, FRCP, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's and St Thomas' Hospital NHSFT, London, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rodney Stables, FRCP, DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Liverpool Cardiothoracic Centre, Liverpool, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martyn Thomas, FRCP, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's and St Thomas' Hospital NHSFT, London, UK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>British Cardiovascular Intervention Society</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S; BCIS-1 Investigators. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013 Jan 15;127(2):207-12. doi: 10.1161/CIRCULATIONAHA.112.132209. Epub 2012 Dec 6.</citation>
    <PMID>23224207</PMID>
  </results_reference>
  <results_reference>
    <citation>Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S; BCIS-1 Investigators. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010 Aug 25;304(8):867-74. doi: 10.1001/jama.2010.1190.</citation>
    <PMID>20736470</PMID>
  </results_reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 28, 2009</study_first_submitted>
  <study_first_submitted_qc>May 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2009</study_first_posted>
  <results_first_submitted>February 6, 2021</results_first_submitted>
  <results_first_submitted_qc>February 6, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 25, 2021</results_first_posted>
  <last_update_submitted>February 6, 2021</last_update_submitted>
  <last_update_submitted_qc>February 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>British Cardiovascular Intervention Society</investigator_affiliation>
    <investigator_full_name>Dr Divaka Perera</investigator_full_name>
    <investigator_title>Professor of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Percutaneous Transluminal Coronary Angioplasty</keyword>
  <keyword>Intraaortic Balloon Pumping</keyword>
  <keyword>Left Ventricular Dysfunction</keyword>
  <keyword>High Risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Elective IABP Insertion</title>
          <description>Intra-Aortic Balloon Pump: Elective IABP insertion before PCI</description>
        </group>
        <group group_id="P2">
          <title>No Planned IABP Insertion</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="151"/>
                <participants group_id="P2" count="150"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="151"/>
                <participants group_id="P2" count="150"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Elective IABP Insertion</title>
          <description>Left ventricular ejection fraction was 23.6% (SD, 5.2%) in the elective IABP group</description>
        </group>
        <group group_id="B2">
          <title>No Planned IABP Insertion</title>
          <description>Left ventricular ejection fraction was 23.6% (SD, 5.5%) in the no planned IABP group</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="151"/>
            <count group_id="B2" value="150"/>
            <count group_id="B3" value="301"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="122"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Major Adverse Cardiac and Cerebrovascular Events</title>
        <description>(composite endpoint of death, acute myocardial infarction, further revascularization or cerebrovascular event)</description>
        <time_frame>Hospital discharge or 28 days following PCI, whichever occurs sooner</time_frame>
        <population>All</population>
        <group_list>
          <group group_id="O1">
            <title>Elective IABP Insertion</title>
            <description>Intra-Aortic Balloon Pump: Elective IABP insertion before PCI</description>
          </group>
          <group group_id="O2">
            <title>No Planned IABP Insertion</title>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Cardiac and Cerebrovascular Events</title>
          <description>(composite endpoint of death, acute myocardial infarction, further revascularization or cerebrovascular event)</description>
          <population>All</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="151"/>
                <count group_id="O2" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All-cause Mortality</title>
        <time_frame>6-months following randomization</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Procedural Complications</title>
        <time_frame>Duration of PCI procedure</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Bleeding Complications (Major and Minor)</title>
        <time_frame>Hospital Discharge or 28 days following PCI (whichever occurs sooner)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Access Site Complications</title>
        <time_frame>Hospital Discharge or 28 days following PCI (whichever occurs sooner)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Transient Ischemic Attack</title>
        <time_frame>Hospital Discharge or 28 days following PCI (whichever occurs sooner)</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <time_frame>Hospital Discharge</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Success</title>
        <time_frame>Duration of PCI procedure</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Elective IABP Insertion</title>
          <description>Intra-Aortic Balloon Pump: Elective IABP insertion before PCI</description>
        </group>
        <group group_id="E2">
          <title>No Planned IABP Insertion</title>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="151"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="150"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="151"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>CVA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="151"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="151"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Procedural Complications</sub_title>
                <description>Overall, rescue IABP insertion was required in 18 patients assigned to have no planned IABP insertion, including 13 for procedural hypotension, 1 for pulmonary edema, and 1 for sudden vessel closure.</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="151"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Divaka Perera</name_or_title>
      <organization>King's College London</organization>
      <phone>02071887188</phone>
      <email>divaka.perera@kcl.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

